Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived mesenchymal stromal cells for mild to moderate knee osteoarthritis
2015-002125-19Phase 2Completed
- Sponsor
- CHU Montpellier
- Start
- May 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous adipose-derived mesenchymal stromal cells in knee osteoarthritis (OA) (3 arms), sponsored by CHU Montpellier. Primary endpoint: Primary efficacy analysis. Started May 2016; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2015-002125-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002125-19.